Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Continued as: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume 5, 4 Issues, 2005
ISSN: 1875-5917 (Online)
ISSN: 1568-0088 (Print)
This journal supports open access
ISSN: 1875-5917 (Online)
ISSN: 1568-0088 (Print)
This journal supports open access
Contents
Current Drug Targets - Immune, Endocrine & Metabolic Disorders , Volume 5 - Number 2
Editorial [(Guest Editors: Piero Portincasa and K.J. van Erpecum) Hot Topic: New Insights Into Bile Formation: from Secretion to Therapeutic ]
, 5(2): 129 - 130Piero Portincasa and KJ van Erpecum
DOI: 10.2174/1568005310505020129
Lipid Transport into Bile and Role in Bile Formation
, 5(2): 131 - 135Albert K. Groen and Ronald P.J. Oude Elferink
DOI: 10.2174/1568008054064887
Water Transport into Bile and Role in Bile Formation
, 5(2): 137 - 142Giuseppe Calamita, Domenico Ferri, Patrizia Gena, Giuseppa E. Liquori, Raul A. Marinelli, Giuliano Meyer, Piero Portincasa and Maria Svelto
DOI: 10.2174/1568005310505020137
Ion Transport Across the Gallbladder Epithelium
, 5(2): 143 - 151G. Meyer, F. Guizzardi, S. Rodighiero, R. Manfredi, S. Saino, C. Sironi, M. L. Garavaglia, C. Bazzini, G. Botta, P. Portincasa, G. Calamita and M. Paulmichl
DOI: 10.2174/1568008054064805
Contribution of Canalicular Glutathione Efflux to Bile Formation. From Cholestasis Associated Alterations to Pharmacological Intervention to Modify Bile Flow
, 5(2): 153 - 161Ignazio Grattagliano, Piero Portincasa, Vincenzo O. Palmieri and Giuseppe Palasciano
DOI: 10.2174/1568005310505020153
The Genetic Background of Cholesterol Gallstone Formation: An Inventory of Human Lithogenic Genes
, 5(2): 163 - 170Frank Lammert and Siegfried Matern
DOI: 10.2174/1568005310505020163
Modulation of Cholesterol Crystallization in Bile. Implications for Non- Surgical Treatment of Cholesterol Gallstone Disease
, 5(2): 177 - 184Piero Portincasa, Antonio Moschetta, Karel J. van Erpecum, Michele Vacca, Michele Petruzzelli, Giuseppe Calamita, Giuliano Meyer and Giuseppe Palasciano
DOI: 10.2174/1568005310505020177
Drugs Affecting Biliary Lipid Secretion and Gallbladder Motility: Their Potential Role in Gallstone Treatment and Prevention
, 5(2): 185 - 191Gerard P. vanBerge-Henegouwen, Niels G. Venneman, Karel J. van Erpecum and Piero Portincasa
DOI: 10.2174/1568005310505020185
Pharmacological Manipulation of Biliary Water and Lipids: Potential Consequences for Prevention of Acute Biliary Pancreatitis
, 5(2): 193 - 198Niels G. Venneman, Gerard P. vanBerge-Henegouwen and Karel J. van Erpecum
DOI: 10.2174/1568008054064814
Effects of Leptin on Biliary Lipids: Potential Consequences for Gallstone Formation and Therapy in Obesity
, 5(2): 203 - 208Nahum Mendez-Sanchez, Guadalope Ponciano-Rodrigoez, Norberto Chavez-Tapia and Misael Uribe
DOI: 10.2174/1568005310505020203
Assessment of Modes of Action and Efficacy of Plasma Cholesterol- Lowering Drugs: Measurement of Cholesterol Absorption, Cholesterol Synthesis and Bile Acid Synthesis and Turnover Using Novel Stable Isotope Techniques
, 5(2): 209 - 218Frans Stellaard and Folkert Kuipers
DOI: 10.2174/1568005310505020209
Therapeutic Targets for the Prevention of Type 1 Diabetes Mellitus
, 5(2): 227 - 236N. Singh and J. P. Palmer
DOI: 10.2174/1568005310505020227
The Mammalian Innate Immune System: Potential Targets for Drug Development
, 5(2): 237 - 247Thomas T. Wheeler and Kylie A. Hood
DOI: 10.2174/1568005310505020237
Webmaster Contact: info@benthamscience.net